 Connection
Vladimir Zharov to Rats
This is a "connection" page, showing publications Vladimir Zharov has written about Rats.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.872 |
|
|
|
-
Sarimollaoglu M, Stolarz AJ, Nedosekin DA, Garner BR, Fletcher TW, Galanzha EI, Rusch NJ, Zharov VP. High-speed microscopy for in vivo monitoring of lymph dynamics. J Biophotonics. 2018 08; 11(8):e201700126.
Score: 0.096
-
Nolan J, Sarimollaoglu M, Nedosekin DA, Jamshidi-Parsian A, Galanzha EI, Kore RA, Griffin RJ, Zharov VP. In Vivo Flow Cytometry of Circulating Tumor-Associated Exosomes. Anal Cell Pathol (Amst). 2016; 2016:1628057.
Score: 0.089
-
Galanzha EI, Nedosekin DA, Sarimollaoglu M, Orza AI, Biris AS, Verkhusha VV, Zharov VP. Photoacoustic and photothermal cytometry using photoswitchable proteins and nanoparticles with ultrasharp resonances. J Biophotonics. 2015 Jan; 8(1-2):81-93.
Score: 0.072
-
Galanzha EI, Shashkov E, Sarimollaoglu M, Beenken KE, Basnakian AG, Shirtliff ME, Kim JW, Smeltzer MS, Zharov VP. In vivo magnetic enrichment, photoacoustic diagnosis, and photothermal purging of infected blood using multifunctional gold and magnetic nanoparticles. PLoS One. 2012; 7(9):e45557.
Score: 0.067
-
Galanzha EI, Sarimollaoglu M, Nedosekin DA, Keyrouz SG, Mehta JL, Zharov VP. In vivo flow cytometry of circulating clots using negative photothermal and photoacoustic contrasts. Cytometry A. 2011 Oct; 79(10):814-24.
Score: 0.062
-
Biris AS, Galanzha EI, Li Z, Mahmood M, Xu Y, Zharov VP. In vivo Raman flow cytometry for real-time detection of carbon nanotube kinetics in lymph, blood, and tissues. J Biomed Opt. 2009 Mar-Apr; 14(2):021006.
Score: 0.052
-
Galanzha EI, Shashkov EV, Tuchin VV, Zharov VP. In vivo multispectral, multiparameter, photoacoustic lymph flow cytometry with natural cell focusing, label-free detection and multicolor nanoparticle probes. Cytometry A. 2008 Oct; 73(10):884-94.
Score: 0.051
-
Galanzha EI, Tuchin VV, Zharov VP. Advances in small animal mesentery models for in vivo flow cytometry, dynamic microscopy, and drug screening. World J Gastroenterol. 2007 Jan 14; 13(2):192-218.
Score: 0.045
-
Galanzha EI, Tuchin VV, Zharov VP. Optical monitoring of microlymphatic disturbances during experimental lymphedema. Lymphat Res Biol. 2007; 5(1):11-27.
Score: 0.045
-
Zharov VP, Galanzha EI, Menyaev Y, Tuchin VV. In vivo high-speed imaging of individual cells in fast blood flow. J Biomed Opt. 2006 Sep-Oct; 11(5):054034.
Score: 0.044
-
Zharov VP, Galanzha EI, Tuchin VV. In vivo photothermal flow cytometry: imaging and detection of individual cells in blood and lymph flow. J Cell Biochem. 2006 Apr 01; 97(5):916-32.
Score: 0.043
-
Galanzha EL, Chowhury P, Tuchim VV, Zharov VP. Monitoring of nicotine impact in microlymphatics of rat mesentery with time-resolved microscopy. Lymphology. 2005 Dec; 38(4):181-92.
Score: 0.042
-
Galanzha EI, Tuchin VV, Zharov VP. In vivo integrated flow image cytometry and lymph/blood vessels dynamic microscopy. J Biomed Opt. 2005 Sep-Oct; 10(5):054018.
Score: 0.041
-
Zharov VP, Galitovsky V, Chowdhury P. Nanocluster model of photothermal assay: application for high-sensitive monitoring of nicotine-induced changes in metabolism, apoptosis, and necrosis at a cellular level. J Biomed Opt. 2005 Jul-Aug; 10(4):44011.
Score: 0.040
-
Zharov VP, Galanzha EI, Tuchin VV. Photothermal image flow cytometry in vivo. Opt Lett. 2005 Mar 15; 30(6):628-30.
Score: 0.040
-
Stolarz AJ, Sarimollaoglu M, Marecki JC, Fletcher TW, Galanzha EI, Rhee SW, Zharov VP, Klimberg VS, Rusch NJ. Doxorubicin Activates Ryanodine Receptors in Rat Lymphatic Muscle Cells to Attenuate Rhythmic Contractions and Lymph Flow. J Pharmacol Exp Ther. 2019 11; 371(2):278-289.
Score: 0.027
-
Nedosekin DA, Verkhusha VV, Melerzanov AV, Zharov VP, Galanzha EI. In vivo photoswitchable flow cytometry for direct tracking of single circulating tumor cells. Chem Biol. 2014 Jun 19; 21(6):792-801.
Score: 0.019
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|